Combining Three Cancer Drugs for Better Treatment
Author Information
Author(s): Fischel J-L, Rostagno P, Formento P, Dubreuil A, Etienne M-C, Milano G
Primary Institution: Oncopharmacology Unit, Centre Antoine Lacassagne
Hypothesis
The study aims to compare two schedules of combining irinotecan with fluorouracil-folinic acid and oxaliplatin in human colon cancer cell lines.
Conclusion
The sequence in which the drugs are administered significantly affects their combined effectiveness against cancer cells.
Supporting Evidence
- The study found that the order of drug administration affects the overall cytotoxicity.
- When SN38 was given first, the combination showed a synergistic effect.
- The largest contribution to cytotoxicity came from oxaliplatin.
Takeaway
This study looks at how different orders of giving cancer drugs can change how well they work together to kill cancer cells.
Methodology
The study used two human colon cancer cell lines and assessed cytotoxicity through the MTT test, analyzing drug interactions with the Chou and Talalay method.
Statistical Information
P-Value
0.03
Statistical Significance
p=0.03
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website